# Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/targeted-release-budesonide-versus-placebo-in-patients-with-iga-nephropathy/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Bengt Fellström,Jonathan Barratt,H. Terence Cook,Rosanna Coppo,John Feehally,Johan W. de Fijter,Jürgen Floege,Gerd R. Hetzel,Alan G. Jardine,Francesco Locatelli,Bart Maes,Alex Mercer,Fernanda Ortiz,Manuel Praga,Søren Schwartz Sørensen,Vladimı́r Tesař,Lucia Del Vecchio |
| Citations | 407 |
| DOI | 10.1016/s0140-6736(17)30550-0 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | http://hdl.handle.net/10138/236232 |
| OpenAlex ID | https://openalex.org/W2600347335 |
| PMID | 28363480 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Rosanna Coppo](https://scholariq.org/researchers/rosanna-coppo/)
- [Jonathan Barratt](https://scholariq.org/researchers/jonathan-barratt/)
- [John Feehally](https://scholariq.org/researchers/john-feehally/)
- [Vladimı́r Tesař](https://scholariq.org/researchers/vladim-r-tesar/)
- [Jürgen Floege](https://scholariq.org/researchers/jurgen-floege/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Paper topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.